Looking at the quality of the underlying entities, I think they consider MET a solid performer over the next twelve to eighteen months. Congrats to management for getting them on board.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025